Januvia Weighs Down Merck's Sales

Merck reported disappointing first-quarter sales weighed down by a slowdown of its Januvia diabetes drug and cut its profit forecast for the full year.
Author:
Publish date:

Brittany joined TheStreet.com TV in November 2006 after completing a degree in Journalism and Media Studies at Rutgers College. Previously, Brittany interned at the local ABC affiliate in New York City WABC-TV 7 where she helped research and produce On Your Side, a popular consumer advocacy segment.